- In July 2021, Stryker announced the acquisition of OrthoSpace, Ltd., with an aim to enlarge its sports medicine product offerings, including surgical products for rotator cuff tear treatment.
- In December 2021, DePuy Synthes announced the launch of Inhance, a fully integrated shoulder arthroplasty system.
- n August 2023, Kaneka Corporation, a chemical company from Japan, started testing a treatment called KA-301 made from stem cells derived from human amnion (part of the placenta) on people with acute spinal cord injuries.
- In September 2023, NervGen Pharma Corporation, a biotech company, announced that they'd given the first dose of their experimental drug NVG-291 to someone in a trial for spinal cord injuries
